Tuesday, September 15, 2026

Gilead Launches CAR-T Therapy Yescarta in Korea, Offering Fourfold Survival Benefit for Relapsed or Refractory Lymphoma Patients

Yescarta is widely used for second-line treatment in patients with very low survival rates, and should be adopted as a standard treatment in Korea.

North Korea Hails ‘Blood-Forged’ Friendship With Russia in Pyongyang Visit

Kim Jong Un met with Russian Culture Minister Olga Lyubimova to celebrate a treaty anniversary and discuss cultural cooperation.

U.S.-Russia Relations: A New Twist in Historical Military Graphics

On June 22, the U.S. Eighth Army...

Ji Yea Lee

Author's Latest

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.